Clinical Trial

An Observational Study of Coronary Microvascular Disease of China

Study acronym: CCMD
Recruiting
View on ClinicalTrials.gov →
Summary
Non-obstructive coronary heart disease refers to patients with angina pectoris without significant narrowing of the epicardial vessels. Coronary microvascular disease(CMD) is a kind of non-obstructive coronary heart disease, and its clinical detection rate is increasing, seriously affecting the quality of life of patients, and increasing the risk of cardiovascular adverse events, but its mechanism has not been fully understood. This study will prospectively collect patients who meet the diagnosis of CMD, observe the development and outcome of the disease, and explore its occurrence and development mechanism.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-04.
Trial Details
NCT Number NCT06676137
Lead Sponsor Henan Institute of Cardiovascular Epidemiology
Conditions Coronary Microvascular Disease
Enrollment 500 participants
Start Date 2024-11-11
Primary Completion 2028-10-10 (estimated)
Study Completion 2029-10-10 (estimated)
Updated on ClinicalTrials.gov 2025-08-20